Biotech News

Tomorrow, it happens again — with wrenching familiarity — at Eli Lilly and Co. Another top-selling Lilly drug loses U.S. patent protection, opening the door to cheaper-priced generics that will immediately start grabbing prescription share worth billions of dollars in annual sales.

The European Commission has fined pharmaceuticals giants Johnson & Johnson and Novartis a combined $22 million for colluding to delay the entrance of a cheap generic form of a pain killer to the Dutch market.

Scientists convert common plastic materials like PET into non-toxic materials designed to specifically target and attack fungal infections, including athlete's foot and yeast infections.

Scientists at the company started a long history of innovation in 1978 by successfully expressing a human gene in bacteria that allowed them to produce human insulin.

The U.S. Supreme Court on Monday left intact a $142 million jury verdict against Pfizer Inc. over the company's marketing of the epilepsy drug Neurontin.

Specialty drugmaker United Therapeutics Corp. said Monday that it received a subpoena from federal regulators looking into the company's marketing of three drugs used to treat a form of hypertension.

U.S. Centers for Disease Control and Prevention meningitis expert Thomas Clark says that shortly after vaccinations began at noon Monday, scores of students were in line and some had received the dose.

Medical devices firm DePuy is to create 38 new jobs as part of an expansion of its facility in Ringaskiddy, Co Cork.

Sovaldi , a new drug that can treat hepatitis C infections, has been approved for sale by the US Food and Drug Administration , agency officials confirmed on Friday.

A newspaper investigation reveals that Americans overpay for a vision treatment when a cheaper version is available at 1/40th the cost.

Applications are being accepted for $8 million in grants designed to improve the delivery of mental health and substance abuse services in Massachusetts.

Electronic billboards are reflected in the windows of Nasdaq in New York. Initial public offerings of biotechnology companies have gone from hot to cold in November 2013.

Teva Pharmaceutical Industries, the world's biggest maker of generic drugs, estimates its pipeline of so-called new therapeutic entities could generate revenue of $1 billion to $1.5 billion by 2018.

Jose Luis Alonso, 68, of Paducah, passed away at 1:52 p.m. Thursday, December 5, 2013, at Baptist Health Paducah.

Fewer women in the United States are having babies, according to the latest figures from the Centers for Disease Control and Prevention .

Gilead Sciences, Inc. today announced interim results from a single-arm, open-label Phase 2 study evaluating GS-9973, an investigational oral inhibitor of spleen tyrosine kinase , for the treatment of patients with relapsed or refractory hematologic malignancies.

SAC Capital Advisors LP founder Steven Cohen may help former fund manager Mathew Martoma defend against insider-trading charges next month at trial even if Cohen asserts his legal right to avoid testifying.

In this Thursday, Nov. 14, 2013, file photo, retired U.S. Air Force Master Sgt. Thomas Gipson, of Atlanta, right, has his resume looked over by Ralph Brown, a management and program analyst with the Centers for Disease Control and Prevention, during a job fair for veterans at the VFW Post 2681,Marietta, Ga.

A long-awaited study by the U.S. Centers for Disease Control and Prevention confirms a link between tainted tap water at a U.S. Marine Corps base in North Carolina and increased risk of serious birth defects and childhood cancers.

U.S. health regulators on Friday approved Auxilium Pharmaceuticals Inc's Xiaflex injections to treat a condition that causes a painful curvature of the penis called Peyronie's disease.